U. Warmers, W.A. Konig / Phytochemistry 52 (1999) 695±704
È
703
H-5); MS (EI, 70 eV): m/z (rel.int.) 220 (24) [M+], 205
(9) [M+-CH3], 202 (6) [M+-H2O], 187 (3) [M+-H2O-
CH3], 163 (25), 162 (11), 159 (16), 147 (10), 145 (11),
133 (10), 132 (11), 121 (12), 119 (28), 110 (41), 109
(100), 108 (78), 107 (14), 106 (11), 105 (29), 95 (26), 93
(24), 92 (11), 91 (30), 81 (19), 80 (12), 79 (21), 77 (21),
69 (33), 67 (19), 56 (15), 55 (26), 53 (19), 43 (24), 41
(58), 39 (23).
(3H, s, H-12), 1.67±1.75 (1H, m H-9a/b), 1.79±1.87
(1H, m, H-5a/b), 1.87±1.92 (1H, m, H-10), 1.91-1.99
(1H, m, H-2a/b), 1.97±2.04 (2H, m, H-5a/b, H-6a),
2.11 (1H, dm, J = 17.7 Hz, H-2a/b), 2.21±2.29 (1H,
m, H-8a/b), 2.29±2.39 (1H, m, H-8a/b), 5.32 (1H, bs,
H-3); 13C NMR (125 MHz, CDCl3): d 15.66 (q, C-14),
20.22 (q, C-12), 23.55 (q, C-15), 23.96 (q, C-13), 27.60
(t, C-6), 28.60 (t, C-5), 29.82 (t, C-9), 30.42 (t, C-8),
35.06 (t, C-2), 41.12 (d, C-10), 46.66 (s, C-1), 120.75
(d, C-3), 122.65 (s, C-11), 134.28 (s, C-4), 140.69 (s, C-
7); MS (EI, 70 eV): m/z (rel.int.) 204 (13) [M+], 189
(2) [M+±CH3], 161 (10), 137 (6), 136 (58), 122 (10),
121 (100), 119 (6), 107 (6), 105 (8), 93 (10), 79 (7), 55
(4), 53 (4), 41 (10).
3.11. Hydrogenation of (+)-cadina-1(10),3,7(11)-
triene (2)
To a sol. of 0.5 mg of 2 in 1 ml n-hexane 0.3 mg
Pd/C were added. The suspension was treated with H2
and stirred under H2 at room temp. for 1 h. The reac-
tion product was ®ltered and analysed by GC-MS and
by GC on several capillary columns with cyclodextrin
phases.
3.15. Dehydration of ( )-a-alasken-6b-ol (7) to 5,6-
dehydro-a-alaskene (9)
The dehydration of 7 was performed analogously to
the dehydration of 1. The reaction products were ana-
lysed by GC-MS. 9 was the main reaction product. 9:
MS (EI, 70 eV): m/z (rel. int.) 202 (24) [M+], 187 (32)
[M+±CH3], 173 (14), 161 (19), 159 (40), 147 (17), 146
(20), 145 (80), 133 (15), 132 (28), 131 (53), 129 (16),
128 (16), 120 (15), 119 (75), 117 (24), 115 (20), 107
(32), 106 (26), 105 (100), 95 (10), 93 (24), 92 (24), 91
(64), 81 (15), 79 (25), 77 (40), 68 (16), 67 (19), 65 (21),
55 (28), 53 (29), 41 (66).
3.12. Hydrogenation of (+)-d-cadinene (6)
The hydrogenation of 6 was performed analogously
to the hydrogenation of 2. The reaction products were
analysed by GC-MS and by GC on various capillary
columns with cyclodextrin phases. The hydrogenation
products of 6 and 2 were compared. Some of the
major constituents of the obtained saturated cadinanes
show identical retention times on achiral GC phases,
but dierent retention times on chiral GC phases.
3.16. ( )-a-Alasken-8-one (10)
3.13. ( )-a-Alasken-6b-ol (7)
1H NMR (500 MHz, CDCl3): d 0.94 (3H, d, J = 7.0
Hz, H-14), 1.70 (3H, s, H-15), 1.71±1.75 (1H, dm,
J = 14.5 Hz, H-6b), 1.74±1.79 (1H, m, H-6a), 1.91
(1H, dd, J = 17.5, 2.9 Hz, H-9a), 1.93 (3H, s, H-12),
2.05±2.14 (4H, m, H-2b, H-5a, H-5b, H-10), 2.16±2.24
(1H, m, H-2a), 2.23 (3H, s, H-13), 2.53 (1H, dd,
J = 17.5, 7.9 Hz, H-9b), 5.34 (1H, bs, H-3); 13C NMR
(125 MHz, CDCl3): d 16.77 (q, C-14), 23.46 (q, C-15),
23.54 (q, C-12), 23.89 (q, C-13), 27.85 (t, C-5), 27.99
(t, C-6), 33.59 (d, C-10), 34.38 (t, C-2), 45.73 (t, C-9),
46.35 (s, C-1), 119.93 (d, C-3), 134.68 (s, C-4), 138.31
(s, C-7), 149.49 (s, C-11), 208.62 (s, C-8); 1H NMR
(500 MHz, C6D6): d 0.78 (3H, d, J = 7.0 Hz, H-14),
1.57±1.63 (1H, m, H-6), 1.65 (6H, s, H-12, H-15),
1.66±1.74 (1H, m, H-6), 1.83±1.92 (2H, m, H-9, H-10),
1.83±1.94 (2H, m, H-5a, H-5b), 1.90±1.98 (1H, m, H-
2), 2.05±2.12 (1H, m, H-2), 2.37 (3H, s, H-13), 2.40
(1H, dd, J = 17.5, 7.9 Hz, H-9), 5.26 (1H, bs, H-3);
13C NMR (125 MHz, C6D6): d 16.64, 23.11, 23.50,
23.70, 27.93, 28.17, 33.72, 34.51, 45.69, 46.27, 120.44,
134.23, 138.45, 147.89, 206.48; MS (EI, 70 eV): m/z
(rel.int.) 218 (28) [M+], 203 (3) [M+±CH3], 197 (2),
177 (9), 151 (11), 150 (100), 136 (8), 135 (81), 121 (8),
107 (33), 105 (13), 93 (10), 91 (27), 79 (20), 77 (20), 65
(10), 53 (15), 41 (31), 39 (20).
1H NMR (400 MHz, CDCl3): d 1.08 (3H, d, J = 7.1
Hz, H-14), 1.24±1.32 (1H, m, H-9a), 1.70 (6H, s, H-
13, H-15), 1.72±1.80 (1H, m, H-9b), 1.83 (3H, bs, H-
12), 2.02 (1H, dd, J = 4.6, 17.3 Hz, H-2b), 2.08±2.15
(1H, m, H-2a), 2.12±2.19 (1H, m, H-10), 2.18±2.29
(1H, m, H-5a), 2.25±2.35 (1H, m, H-8a/b), 2.27±2.37
(1H, m, H-5b), 2.36±2.47 (1H, m, H-8a/b), 4.57 (1H,
dd, J = 5.6, 10.4 Hz, H-6), 5.22 (1H, bs, H-3); 13C
NMR (125 MHz, CDCl3): d 18.00 (q, C-14), 19.49 (q,
C-12), 23.08 (q, C-13), 24.51 (q, C-15), 30.63 (t, C-9),
30.90 (t, C-8), 35.90 (t, C-5), 37.22 (t, C-2), 39.39 (d,
C-10), 54.09 (s, C-1), 71.97 (d, C-6), 119.97 (d, C-3),
124.49 (s, C-11), 132.92 (s, C-4), 137.35 (s, C-7); MS
(EI, 70 eV): m/z (rel.int.) 220 (7) [M+], 202 (12) [M+-
H2O], 187 (9) [M+±H2O±CH3], 159 (17), 153 (11), 152
(100), 145 (12), 137 (17), 131 (9), 123 (29), 121 (11),
119 (14), 109 (9), 105 (17), 91 (14), 81 (15), 77 (10), 67
(9), 55 (8), 41 (17).
3.14. ( )-a-Alaskene (8)
1H NMR (500 MHz, CDCl3): d 0.87 (3H, d, J = 7.0
Hz, H-14), 1.25±1.33 (1H, m, H-9a/b), 1.53±1.61 (1H,
m, H-6b), 1.62 (3H, s, H-13), 1.67 (3H, s, H-15), 1.70